Featured Research

from universities, journals, and other organizations

Flavonoids May Inhibit Prostate Cancer

Date:
October 21, 2005
Source:
Case Western Reserve University
Summary:
Researchers orally fed the flavonoid apigenin to mice two weeks before implanting a prostate tumor, then continuing the feedings for eight weeks. In a second protocol, apigenin was fed to mice two weeks after tumor implantation. The first protocol mimicked prevention regimens, while the second followed therapeutic regimens for cancer. In both cases, the apigenin slowed tumor growth and did not appear to cause any adverse side effects.

Eating a diet rich in fruits and vegetables could be a good defense against prostate cancer, according to a Case Western Reserve University study published in the October online issue of the Federation of American Societies for Experimental Biology Journal.

Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology. Apigenin is a plant flavonoid commonly found in fruits and vegetables, as well as herbs, including chamomile, lemon balm, perilla and parsley.

"Flavonoids have aroused considerable interest recently because of their potential beneficial effects on human health, and have reported to have antiviral, anti-allergic, antiplatelet, anti-inflammatory, antitumor and antioxidant activities," Gupta said. "Apigenin has been shown to lower inflammation and oxidative stress, and exerts growth inhibitory effects on cancer cells."

In the study, Gupta and his team orally fed apigenin to mice two weeks before implanting a prostate tumor, then continuing the feedings for eight weeks. In a second protocol, apigenin was fed to mice two weeks after tumor implantation.

The first protocol mimicked prevention regimens, while the second followed therapeutic regimens for cancer.

In both cases, the apigenin slowed tumor growth and did not appear to cause any adverse side effects such as weight gain or changes in diet, which is common in patients who undergo chemotherapy treatments.

Apigenin also resulted in a decrease in IGF-1 (insulin-like growth factor) levels, which are associated with an increased risk of breast, prostate, colorectal and lung cancers, as well as a significant increase in IGFBP-3 (insulin-like growth factor binding protein) levels, which is associated with a decreased risk for these same cancers. The effect impacts the survival of prostate cancer by triggering cell self-destruction.

"Apigenin may prove useful in the prevention and therapy of prostate cancer by shutting off the IGF signaling that leads to prostate cancer cell growth and/or development," Gupta said.

"Our findings suggest that apigenin could be developed as a promising agent against prostate cancer," Gupta said. "The next step is to evaluate apigenin action on other molecular pathways which have relevance to prostate cancer."

Gupta's colleagues contributing to the study included Sanjeev Shukla, Ph.D.; Gregory T. MacLennan, M.D.; Pingfu Fu, Ph.D.; Martin I. Resnick, M.D.; from Case Western Reserve University and University Hospitals of Cleveland, and Anil Mishra, Ph.D. from University of Pittsburgh.


Story Source:

The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.


Cite This Page:

Case Western Reserve University. "Flavonoids May Inhibit Prostate Cancer." ScienceDaily. ScienceDaily, 21 October 2005. <www.sciencedaily.com/releases/2005/10/051021021503.htm>.
Case Western Reserve University. (2005, October 21). Flavonoids May Inhibit Prostate Cancer. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2005/10/051021021503.htm
Case Western Reserve University. "Flavonoids May Inhibit Prostate Cancer." ScienceDaily. www.sciencedaily.com/releases/2005/10/051021021503.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins